J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
India · Delayed Price · Currency is INR | Market Cap | 321.75B +31.8% |
| Revenue (ttm) | 41.93B +9.5% |
| Net Income | 7.54B +17.8% |
| EPS | 47.47 +18.1% |
| Shares Out | n/a |
| PE Ratio | 42.68 |
| Forward PE | 35.45 |
| Dividend | 19.70 (0.98%) |
| Ex-Dividend Date | Feb 11, 2026 |
| Volume | 225,295 |
| Average Volume | 328,526 |
| Open | 2,011.50 |
| Previous Close | 2,011.50 |
| Day's Range | 1,991.00 - 2,018.20 |
| 52-Week Range | 1,494.80 - 2,195.00 |
| Beta | -0.00 |
| RSI | 49.44 |
| Earnings Date | May 15, 2026 |
About NSE:JBCHEPHARM
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and h... [Read more]
Financial Performance
In fiscal year 2025, NSE:JBCHEPHARM's revenue was 39.18 billion, an increase of 12.45% compared to the previous year's 34.84 billion. Earnings were 6.60 billion, an increase of 19.35%.
Financial StatementsNews
JB Chemicals calls shareholders' meeting under National Company Law Tribunal order
JB Chemicals & Pharmaceuticals has announced a meeting of its equity shareholders convened pursuant to an order issued by the National Company Law Tribunal (NCLT), Ahmedabad Bench, on March 23,…
Stocks to buy: What's the outlook for Nifty for March 23-27 week? Check list of top stock recommendations
Stock market recommendations: Coal India, and JB Chemicals and Pharmaceuticals stocks that Sudeep Shah, Head - Technical Research and Derivatives, SBI Securities recommends buying for the week startin...
JB Chemicals announces resignation of Sushree Mishra as General Manager
Sushree Mishra has resigned from her position as General Manager-Corporate Strategy, Communication and In-licensing at JB Chemicals & Pharmaceuticals, effective from the close of business on 13 March ...
JB Chemicals announces resignation of Executive Vice President Jason D'souza
JB Chemicals & Pharmaceuticals has announced the resignation of its Executive Vice President, Jason D'souza, effective from the close of business on 6 March 2026. The company disclosed that the…
JB Chemicals announces resignation of three senior executives
JB Chemicals & Pharmaceuticals has announced the resignation of three senior executives, effective early March 2026. Mr. Kunal Khanna, who served as President – Operations, and Mr. Dilip Singh Rathore...
JB Chemicals announces senior management changes with three resignations
JB Chemicals & Pharmaceuticals has announced significant changes in its senior management team. The company confirmed that Mr. Kunal Khanna, who served as President – Operations, and Mr. Dilip Singh…
Q3 2026 J B Chemicals and Pharmaceuticals Ltd Earnings Call Transcript
Q3 2026 J B Chemicals and Pharmaceuticals Ltd Earnings Call Transcript
J. B. Chemicals & Pharmaceuticals Transcript: Q3 25/26
Q3 FY26 saw 11% revenue growth and 22% net profit growth, with strong domestic and international performance, margin expansion, and robust order books. The merger with Torrent is expected to close in Q4, and no interim dividend has been announced yet.
Q2 2026 J B Chemicals and Pharmaceuticals Ltd Earnings Call Transcript
Q2 2026 J B Chemicals and Pharmaceuticals Ltd Earnings Call Transcript
J. B. Chemicals & Pharmaceuticals Transcript: Q2 25/26
Q2 FY 2026 saw 8% revenue growth and 19% net profit growth, with gross margin up to 68.2% and strong performance in the domestic and CDMO segments. Guidance for 12%-14% growth in domestic and CDMO businesses is maintained, with margin outlook reaffirmed.
Stocks to watch today, Sept 5: Sterlite Tech, JB Chemicals, Bharat Forge, Zydus Lifesciences, Varun Beverages in focus
Indian markets are expected to remain stock-specific on Friday, September 5, 2025, as a series of corporate announcements and strategic developments put several companies in focus. Here are the major ...
J. B. Chemicals & Pharmaceuticals Transcript: Q1 25/26
Q1 FY26 saw 9% revenue growth, 14% net profit rise, and record 30.2% EBITDA margin, with strong domestic and CDMO performance. Torrent Pharma's acquisition and merger plans mark a major strategic shift, while guidance for margins and growth remains robust.
Top stocks to buy today: Stock recommendations for July 28, 2025 - check list
JP Morgan downgraded Bajaj Finance, while Morgan Stanley remained overweight on SBI Life Insurance after positive quarterly results. Macquarie lowered Nestle's target price due to missed estimates and...
Torrent Pharmaceuticals to acquire additional 2.41% stake in JB Chemicals for Rs 620 crore
Torrent Pharmaceuticals Limited has announced that it will acquire up to 2.41% of the equity share capital of JB Chemicals & Pharmaceuticals Limited (JB Chemicals) for a total consideration of approxi...
Torrent set to be 5th largest pharma co
India Business News: New Delhi: Following the acquisition of JB Chemicals & Pharmaceuticals (JB Chem), Torrent Pharma is set to become India's fifth-largest pharmaceut.
Torrent Pharma becomes India’s 5th largest drugmaker
Torrent Pharma's acquisition of JB Chemicals & Pharmaceuticals propels it to become India's fifth-largest pharmaceutical company, capturing a 4.6% market share. This deal significantly strengthens Tor...
Meta, KKR, Lululemon And An Industrial Stock On CNBC's 'Final Trades'
On CNBC's “ Halftime Report Final Trades ,” Bryn Talkington , managing partner of Requisite Capital Management, said KKR & Co. Inc. (NYSE: KKR) is in big-time fundraising mode. The stock will go high...
Torrent in Rs 18,000 crore deal, 2nd largest in pharma sector
Torrent Pharma is set to acquire a controlling stake in JB Chemicals & Pharmaceuticals for approximately Rs 18,000 crore, marking the second-largest pharma deal in India. The acquisition involves purc...
Torrent Pharma revives talks to buy KKR stake in JB Chem
India Business News: NEW DELHI: Ahmedabad-based Torrent Pharma has revived talks with PE major KKR to buy its stake in Mumbai-based JB Chemicals & Pharmaceuticals in a.
Top stocks in focus on June 25: JB Chemicals, Infosys, PTC Industries, HAL, IRCTC, and more
The Indian stock market is set for an eventful session on Wednesday, June 25, with several companies announcing fresh developments that could draw investor attention. Here’s a look at key corporate ne...
J. B. Chemicals & Pharmaceuticals Transcript: Q4 24/25
Q4 FY2025 saw 10% revenue and 15% net profit growth, with strong domestic and CDMO performance, improved margins, and robust cash flow. EBITDA margin guidance was raised to 27-29%, and key brands and new launches are expected to drive future growth.
Stocks in news: HDFC Bank, ICICI Bank, Emcure Pharma, TCS, NIIT, Adani Ports, Zydus, Adani Green among top stocks to watch on April 21
A packed day for equity markets awaits investors with multiple stocks poised to remain in focus today, driven by corporate developments, quarterly earnings announcements, and rating upgrades. In the p...
JB Chemicals & Pharma shares slide 6% after large block deal of 5.7% equity
Shares of JB Chemicals & Pharmaceuticals declined sharply on Thursday, falling 6.68% to ₹1,594.65 on the NSE, following a large block deal involving 5.78% equity. As per exchange data, around 90 lakh ...
Stocks to watch today: Infosys, Wipro, Ashok Leyland, HUL, Bajaj Finance, BSE, NBCC, UPL, Max Financial, JB Chemicals in focus [27 March]
Indian equity markets are likely to witness stock-specific action on Thursday, March 27, as several companies announced key developments, strategic deals, stake sales, and corporate updates. Here’s a ...
Stocks to watch today: JB Chemicals, Infosys, Bajaj Finserv, Wipro, Bharat Forge, Marico, Sterlite Technologies in focus on March 26, 2025
Several key corporate announcements are set to drive investor attention on March 26, with developments across IT, pharma, defence, infra, and financial services sectors. Here are the top stocks likely...